Assessment of Distinct Electrophysiological Parameters in Rectal Biopsies for the Choice of the Best Diagnosis/Prognosis Biomarkers for Cystic Fibrosis

Most cases of Cystic Fibrosis (CF) are diagnosed early in life. However, people with atypical CF forms pose diagnosis dilemmas, requiring laboratory support for diagnosis confirmation/exclusion. analysis of fresh rectal biopsies by Ussing chamber has been the best discriminant biomarker for CF diagn...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in physiology Vol. 11; p. 604580
Main Authors: Silva, Iris A L, Duarte, Aires, Marson, Fernando A L, Centeio, Raquel, Doušová, Tereza, Kunzelmann, Karl, Amaral, Margarida D
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 23-12-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Most cases of Cystic Fibrosis (CF) are diagnosed early in life. However, people with atypical CF forms pose diagnosis dilemmas, requiring laboratory support for diagnosis confirmation/exclusion. analysis of fresh rectal biopsies by Ussing chamber has been the best discriminant biomarker for CF diagnosis/prognosis so far. Here we aimed to evaluate different electrophysiological parameters from Ussing chamber analysis of rectal biopsies from people with CF (PwCF) to establish the one with highest correlations with clinical features as the best CF diagnosis/prognosis biomarker. We analyzed measurements of CFTR-mediated Cl secretion in rectal biopsies from 143 individuals (∼592 biopsies), the largest cohort so far analyzed by this approach. New parameters were analyzed and compared with the previous biomarker, i.e., the IBMX (I)/Forskolin (F)/Carbachol (C)-stimulated short-circuit current (I' ). Correlations with clinical features showed that the best parameter corresponded to voltage measurements of the I/F + (I/F/CCH) response (V ), with higher correlations vs. I' for: sweat chloride (59 vs. 52%), fecal elastase (69 vs. 55%) and lung function, measured by FEV (27 vs. 20%). Altogether data show that V is the most sensitive, reproducible, and robust predictive biomarker for CF diagnosis/prognosis effectively discriminating classical, atypical CF and non-CF groups.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Venkateshwar Mutyam, University of Alabama at Birmingham, United States; Isabelle Sermet-Gaudelus, Institut National de la Santé et de la Recherche Médicale (INSERM), France
This article was submitted to Clinical and Translational Physiology, a section of the journal Frontiers in Physiology
Edited by: Elena Schneider-Futschik, The University of Melbourne, Australia
ISSN:1664-042X
1664-042X
DOI:10.3389/fphys.2020.604580